MoneyWorks4Me

Cipla informs about analyst meet

13 Dec 2021 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it enclosed schedule of Analyst/ Institutional Investor Meeting with the Company to be held on 14-December-2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..